Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in Japan

NCT04551989 · clinicaltrials.gov ↗

COMPLETED

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

Churg-Strauss Syndrome
Eosinophilic Granulomatosis With Polyangiitis

Sponsor

GlaxoSmithKline